Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease.

Abstract

Serial extraction study of Alzheimer's disease (AD) and control brains revealed 4, 3.7 and 3 kD amyloid beta protein (A beta) species accumulated in AD brains. In the fractions extracted with TBS, 10% SDS and formic acid, considerable amounts of A beta species were recovered in SDS fractions besides TBS and formic acid fractions. Immunoblotting with several site-specific antibodies confirmed not only the presence of 4 kD A beta starting at the first amino acid of A beta but also 2 smaller A beta species with modification of their amino-termini in the highly resolutional Tris/Tricine gel system. A beta solubility using these solvents was associated with both modification of the amino-terminus and length of carboxyl-terminus of A beta. Especially, a large amount of modified A beta was found to be accumulated as forms with different solubility in AD brains.

• Authors: Y Harigaya, M Shoji, T Kawarabayashi, M Kanai, T Nakamura, T Iizuka, Y Igeta, T C Saido, N Sahara, H Mori
• Journal: Biochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 211 Issue 3 Pg. 1015-22 (Jun 26 1995) ISSN: 0006-291X [Print] United States
• PMID: 7598687 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Amyloid beta-Peptides
• Antibodies, Monoclonal

Topics

• Aged
• Aged, 80 and over
• Alzheimer Disease
• Amyloid beta-Peptides (chemistry, immunology)
• Antibodies, Monoclonal
• Antibody Specificity
• Brain Chemistry
• Fluoroimmunoassay
• Humans
• Immunoblotting